Novo Nordisk A/S
NONOF
$76.92
$1.301.71%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 16.53% | 7.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.53% | 7.00% | |||
| Cost of Revenue | 3.45% | 12.40% | |||
| Gross Profit | 19.00% | 6.04% | |||
| SG&A Expenses | 18.49% | 5.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -810.58% | 125.47% | |||
| Total Operating Expenses | 11.52% | 5.11% | |||
| Operating Income | 22.09% | 9.19% | |||
| Income Before Tax | 0.29% | 38.62% | |||
| Income Tax Expenses | 0.33% | 36.95% | |||
| Earnings from Continuing Operations | 0.28% | 39.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.28% | 39.06% | |||
| EBIT | 22.09% | 9.19% | |||
| EBITDA | 19.37% | 5.63% | |||
| EPS Basic | 0.42% | 39.23% | |||
| Normalized Basic EPS | 16.97% | 13.30% | |||
| EPS Diluted | 0.44% | 39.19% | |||
| Normalized Diluted EPS | 16.95% | 13.28% | |||
| Average Basic Shares Outstanding | -0.14% | -0.12% | |||
| Average Diluted Shares Outstanding | -0.11% | -0.11% | |||
| Dividend Per Share | -- | -100.00% | |||
| Payout Ratio | -1.00% | -- | |||
